Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

HarmonyRx Highlights 22 Years of Pharmacy Benefits Expertise, Building on Foundation as Broadreach Medical Research (BMR) Ready to Announce with Confidence?

newsfilecorp.com

HarmonyRx Highlights 22 Years of Pharmacy Benefits Expertise, Building on Foundation as Broadreach Medical Research (BMR) Ready to Announce with Confidence? New York, New York--(Newsfile Corp. - July 15, 2026) - Since its founding as Broadreach Medical Research (BMR) in 2004, HarmonyRx has remained committed to transparency, clinical expertise and helping employers optimize pharmacy benefits.

With more than two decades of experience in pharmacy benefits, HarmonyRx has grown alongside a rapidly changing healthcare landscape. As pharmacy costs have increased and benefit models have become more complex, the organization has remained focused on delivering clarity, clinical integrity and measurable value to its clients.

"Since our founding as BMR in 2004, we've actively helped employers navigate and adapt to the ever-changing pharmacy benefits landscape," said Joseph N. Savasta, CEO of HarmonyRx. "That experience has shaped our approach today. We've built HarmonyRx to address the challenges we've seen firsthand, with a model centered on transparency, aligned incentives and clinical oversight."

HarmonyRx's approach reflects a shift away from traditional, rebate-driven pharmacy benefit models toward a more modern framework designed to improve outcomes and control costs. The organization combines clinical-first decision making, transparent pricing and proactive cost management strategies to help employers, advisors and members better navigate the complexities of pharmacy benefits.

Key elements of the HarmonyRx model include:

Transparent, pass-through pricing with aligned incentives

Hands-on clinical oversight to support appropriate utilization

Data-driven insights to identify cost-saving opportunities

A focus on long-term sustainability and improved member experience

While the company has evolved from its origins as BMR, its core mission remains consistent — delivering pharmacy benefits solutions that prioritize clarity, accountability and better health outcomes.

"Our history gives us perspective, but our focus is firmly on the future," Savasta added. "We are committed to continuing to innovate and deliver solutions that meet the needs of today's employers and the members they serve."

Joseph N. Savasta

To view an enhanced version of this graphic, please visit:

https://images.newsfilecorp.com/files/12100/304445_93f4025c845d6b5c_001full.jpg

About HarmonyRx

HarmonyRx is a transparent, clinically driven pharmacy benefits organization focused on delivering better outcomes and meaningful cost savings for employers, advisors and members. Founded in 2004 as Broadreach Medical Research (BMR), the organization brings more than 20 years of pharmacy benefits expertise to a modern model built on transparency, clinical integrity and aligned incentives.

For more information, visit www.harmonyrx.com.

Media Contact:

Denise Haegele

marketing@harmonyrx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/304445

Source: HarmonyRx

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for HarmonyRx or all companies in the Pharmaceuticals, Health industry.

HarmonyRx Highlights 22 Years of Pharmacy Benefits Expertise, Building on Foundation as Broadreach Medical Research (BMR)

2026-07-15 8:15 AM EDT

Gregory Esemplare Appointed Chief Operating Officer of HarmonyRx

2026-04-21 8:25 AM EDT

Broadreach Medical Resources (BMR) Announces Rebrand to HarmonyRx, Reflecting a New Era of Clinical-First Pharmacy Benefit Management

2026-01-07 8:08 AM EST

Feb 27, 2026

An advisor enters a ticker into a brokerage dashboard. A retail investor searches a fund on Yahoo Finance. An institutional analyst checks a terminal feed before a client meeting. In that moment, they are not simply looking for a price quote. They are looking for context. And increasingly, what they see is silence. The global ETF market now exceeds $20 trillion in assets under management. At the end of November 2025, the industry included more than 15,600 products and over 30,000 ...

Economy, Business and Finance

Chemicals

Pharmaceutical

Health

Pharmaceuticals

Health